Safety of Inhaled Proteins for Therapeutic Use
Author:
- 1 January 1998
- journal article
- review article
- Published by SAGE Publications in Journal of Aerosol Medicine
- Vol. 11 (4) , 197-219
Abstract
The use of the inhalation route for delivery of inhaled proteins has received increasing attention recently. The purpose of this article is to review the available information related to the safety aspects of inhaled proteins. The review focuses primarily on possible toxicity to the respiratory tract, because usually one is either considering an agent to treat the lung or an agent for which the systemic toxicity has been investigated following subcutaneous (s.c.) administration in its clinical use as a therapeutic agent. Some background is provided on mechanisms of absorption and reasons why inhalation delivery is considered for many proteins. Available data are summarized from clinical trials of proteins and protein-like biomolecules, generally showing minimal, if any, adverse respiratory effects. The results of the animal toxicology studies that have been published are presented. In general, the observed lung toxicity has been relatively low, and it has been difficult to interpret in cases where the animal protein differs considerably from the human protein. Discussion is presented on the possibility of adverse immune reactions, suggesting that this is not likely to be any greater issue than it is for subcutaneously injected materials. Although the safety information is relatively sparse at present, the available data suggest that the inhalation route can be an attractive route to consider for many therapeutic proteins.Keywords
This publication has 54 references indexed in Scilit:
- Delivery of Biotherapeutics by Inhalation AerosolCritical Reviews™ in Therapeutic Drug Carrier Systems, 1995
- Immunoprophylaxis of atopy: light at the end of the tunnel?Immunology Today, 1994
- Toxicologic Testing of Inhaled Pharmaceutical AerosolsCritical Reviews in Toxicology, 1993
- Dust overloading of the lungs: Update and appraisalToxicology and Applied Pharmacology, 1992
- Effect of inhaled natural interferon-alpha on diffuse bronchioalveolar carcinomaEuropean Journal of Cancer, 1990
- Particle Overload in Toxicological Studies: Friend or Foe?Journal of Aerosol Medicine, 1990
- The Physiologic Replacement of InsulinNew England Journal of Medicine, 1989
- Animal Model of Grain Worker's LungEnvironmental Health Perspectives, 1986
- The New Insulins Their Characteristics and Clinical IndicationsDrugs, 1982
- Dose Response of the Pulmonary Macrophagic System to Various Particulates and Its Relationship to Transepithelial Passage of Free ParticlesExperimental Lung Research, 1981